HomeCompareSAPLF vs JNJ

SAPLF vs JNJ: Dividend Comparison 2026

SAPLF yields 4.50% · JNJ yields 2.14%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 SAPLF wins by $3425.81M in total portfolio value
10 years
SAPLF
SAPLF
● Live price
4.50%
Share price
$1.18
Annual div
$0.05
5Y div CAGR
100%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$3425.85M
Annual income
$3,285,634,213.20
Full SAPLF calculator →
JNJ
Johnson & Johnson
● Live price
2.14%
Share price
$242.49
Annual div
$5.20
5Y div CAGR
28%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$30.5K
Annual income
$4,749.88
Full JNJ calculator →

Portfolio growth — SAPLF vs JNJ

📍 SAPLF pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodSAPLFJNJ
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, SAPLF + JNJ cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
SAPLF pays
JNJ pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

SAPLF
Annual income on $10K today (after 15% tax)
$382.64/yr
After 10yr DRIP, annual income (after tax)
$2,792,789,081.22/yr
JNJ
Annual income on $10K today (after 15% tax)
$182.28/yr
After 10yr DRIP, annual income (after tax)
$4,037.40/yr
At 15% tax rate, SAPLF beats the other by $2,792,785,043.82/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of SAPLF + JNJ for your $10,000?

SAPLF: 50%JNJ: 50%
100% JNJ50/50100% SAPLF
Portfolio after 10yr
$1712.94M
Annual income
$1,642,819,481.54/yr
Blended yield
95.91%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on JNJ right now

SAPLF
No analyst data
Altman Z
6.4
Piotroski
6/9
JNJ
Analyst Ratings
20
Buy
17
Hold
3
Sell
Consensus: Buy
Price Target
$228.73
-5.7% upside vs current
Range: $190.00 — $265.00
Altman Z
5.2
Piotroski
4/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

SAPLF buys
0
JNJ buys
0
No recent congressional trades found for SAPLF or JNJ in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricSAPLFJNJ
Forward yield4.50%2.14%
Annual dividend / share$0.05$5.20
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR100%28%
Portfolio after 10y$3425.85M$30.5K
Annual income after 10y$3,285,634,213.20$4,749.88
Total dividends collected$3415.93M$15.6K
Payment frequencyquarterlyquarterly
SectorStockHealthcare

Year-by-year: SAPLF vs JNJ ($10,000, DRIP)

YearSAPLF PortfolioSAPLF Income/yrJNJ PortfolioJNJ Income/yrGap
1← crossover$11,600$900.34$10,594$274.49+$1.0KSAPLF
2$14,365$1,952.19$11,294$360.69+$3.1KSAPLF
3$19,889$4,518.46$12,133$476.91+$7.8KSAPLF
4$32,974$11,693.56$13,156$635.42+$19.8KSAPLF
5$71,521$36,238.13$14,432$854.61+$57.1KSAPLF
6$223,443$146,915.57$16,056$1,162.76+$207.4KSAPLF
7$1,097,008$857,924.04$18,175$1,604.53+$1.08MSAPLF
8$9,046,770$7,872,971.61$21,009$2,252.68+$9.03MSAPLF
9$131,038,148$121,358,104.80$24,911$3,229.73+$131.01MSAPLF
10$3,425,845,032$3,285,634,213.20$30,458$4,749.88+$3425.81MSAPLF

SAPLF vs JNJ: Complete Analysis 2026

SAPLFStock

Sylvania Platinum Limited primarily engages in the retreatment of platinum group metals (PGM) bearing chrome tailings materials in South Africa and Mauritius. The company produces PGMs, including platinum, palladium, and rhodium. It holds interests in the Sylvania dump operations that comprise six chrome beneficiation and PGM processing plants located in the Eastern and Western Limb of the Bushveld Igneous Complex; and various mineral asset development projects, including Volspruit and Northern Limb projects located on the Northern Limb of the Bushveld Igneous Complex located in South Africa. The company was incorporated in 2010 and is based in Hamilton, Bermuda.

Full SAPLF Calculator →

JNJHealthcare

Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide, but strategically separated its Consumer Health business into Kenvue Inc. in 2023 to focus on its higher-growth, innovation-driven segments; the former Consumer Health brands (including TYLENOL, LISTERINE, and BAND-AID) are now owned by Kenvue. The company's core focus is now split between its Innovative Medicine (formerly Pharmaceutical) segment, which offers prescription products for complex diseases such as rheumatoid arthritis, various cancers, HIV/AIDS, and neurodegenerative disorders; and its MedTech (Medical Devices) segment, which provides advanced technology solutions including electrophysiology products, neurovascular care products, orthopaedics (hips, knees, spine), advanced surgery solutions, and disposable contact lenses under the ACUVUE brand. Company's two remaining segments primarily serve hospitals, healthcare professionals, wholesalers, and retailers, continuing its mission of advancing human health since its founding in 1886 and its current basing in New Brunswick, New Jersey.

Full JNJ Calculator →
📬

Get this SAPLF vs JNJ comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

SAPLF vs SCHDSAPLF vs JEPISAPLF vs OSAPLF vs KOSAPLF vs MAINSAPLF vs ABBVSAPLF vs MRKSAPLF vs PFE

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.